News Coverage 11.06.19 Share on Twitter Share on Facebook Share on LinkedIn Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach Related Announcement, Our Impact, Press Release PICI at ASCO: New Data. Big Impact. Top Honors. Announcement, Partner Highlight, Press Release New PICI Collaboration Bolsters Science-to-Market Edge Announcement, Partner Highlight, Press Release PICI, Immunai to Build Landmark Cancer Dataset
Announcement, Partner Highlight, Press Release New PICI Collaboration Bolsters Science-to-Market Edge